LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

Kodu・Aktsiate loetelu・Quest Diagnostics Inc

Quest Diagnostics Inc

Avatud

Sektor Tervishoid

154.13 -0.7

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

153.88

Max

156.18

Põhinäitajad
By Trading Economics
Sissetulek	-3M 226M
Müük	90M 2.5B
P/E Sektori keskmine	20.95 104.138
Aktsiakasum	2.3
Kasumimarginaal	9.076
Töötajad	40,000
EBITDA	1M 479M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+9.2 upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	30. jaan 2025
Järgmine dividendimakse kuupäev	29. jaan 2025

Turustatistika
By TradingEconomics
Turukapital	13M 17B
Eelmine avamishind	154.83
Eelmine sulgemishind	154.13

Uudiste sentiment

By Acuity

34%

66%

93 / 390 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Bullish Evidence

155.185 / 157.47 Toetus ja vastupanu

Quest Diagnostics Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

3. nov 2024, 23:05 UTC

Peamised uudised

Fitch Affirms Australia's Sovereign AAA Rating, But Warns Of Mounting Budget Risks

3. nov 2024, 21:12 UTC

Tulu

Westpac Says Annual Profit Falls 3%, Upbeat on Prospects -- Update

3. nov 2024, 20:59 UTC

Tulu

Westpac Says Annual Profit Falls 3%, Upbeat on Prospects

3. nov 2024, 23:34 UTC

Peamised uudised

Stocks Poised for Lower Open -- Barrons.com

3. nov 2024, 23:16 UTC

Peamised uudised

Tulu

Berkshire Hathway Earnings Weren't as Bad as They Looked -- Barrons.com

3. nov 2024, 22:50 UTC

Omandamised, ülevõtmised, äriostud

Santos Says Working Interest in PNG LNG Now 39.9%

3. nov 2024, 22:50 UTC

Omandamised, ülevõtmised, äriostud

Santos Says Kumul to Assume $90 Million of Project Finance Debt Associated With Stake

3. nov 2024, 22:49 UTC

Omandamised, ülevõtmised, äriostud

Santos Says Final Payment Takes Total Cash Consideration to $602 Million

3. nov 2024, 22:49 UTC

Omandamised, ülevõtmised, äriostud

Santos Receives Final $241 Million Payment From Kumul

3. nov 2024, 22:48 UTC

Omandamised, ülevõtmised, äriostud

Santos Completes Sale of 2.6% Interest in PNG LNG to Kumul Petroleum

3. nov 2024, 20:37 UTC

Tulu

Westpac FY 2024 Deposits Increased 5% to A$674 Billion

3. nov 2024, 20:37 UTC

Tulu

Westpac FY 2024 Loans Increased 4% to A$807 Billion

3. nov 2024, 20:37 UTC

Tulu

Westpac FY 2024 Impairment Charges 7 Bps of Loans

3. nov 2024, 20:37 UTC

Tulu

Westpac FY 2024 Operating Expenses A$10.94 Billion, Up 7% Excluding Notable Items

3. nov 2024, 20:36 UTC

Tulu

Westpac FY 2024 Non-Interest Income A$2.84 Billion, Down 15%

3. nov 2024, 20:35 UTC

Tulu

Westpac FY 2024 CET1 Level 2 Capital Ratio 12.5%, Up 11 Bps

3. nov 2024, 20:35 UTC

Tulu

Westpac Raises Share Buyback Program by A$1 Billion

3. nov 2024, 20:35 UTC

Tulu

Westpac Final Dividend A$0.76/Share

3. nov 2024, 20:33 UTC

Tulu

Westpac FY 2024 Net Interest Margin Down 1 Bps at 1.95%

3. nov 2024, 20:32 UTC

Tulu

Westpac FY 2024 Revenue A$21.59 Billion, Flat on FY 2023

3. nov 2024, 20:32 UTC

Tulu

Westpac FY Net Profit A$6.99 Billion, Down 3%

3. nov 2024, 18:09 UTC

Peamised uudised

Boeing Had a Big Week. This One Is Even Bigger. -- Barrons.com

3. nov 2024, 10:30 UTC

Peamised uudised

Fed Prepares Rate Cut Amid Economic Contradictions -- WSJ

3. nov 2024, 03:00 UTC

Peamised uudised

Disgraced Lebanese Central Banker Who Was a Fugitive Now Awaits His Fate -- WSJ

2. nov 2024, 13:53 UTC

Peamised uudised

Tulu

Omandamised, ülevõtmised, äriostud

Warren Buffett's Berkshire Hathaway Slashes Apple Stake Again -- Update

2. nov 2024, 13:44 UTC

Tulu

Omandamised, ülevõtmised, äriostud

Berkshire Sold 25% of Its Apple Stock in the Third Quarter -- Barrons.com

2. nov 2024, 13:00 UTC

Peamised uudised

China's EV Makers Set Sights on Latin America in Global Expansion -- WSJ

2. nov 2024, 12:58 UTC

Tulu

Omandamised, ülevõtmised, äriostud

Berkshire Sold 25% of Its Apple Stock in the Third Quarter -- Barrons.com

2. nov 2024, 12:48 UTC

Peamised uudised

Tulu

Omandamised, ülevõtmised, äriostud

Warren Buffett's Berkshire Hathaway Slashes Apple Stake Again -- WSJ

2. nov 2024, 12:32 UTC

Tulu

Berkshire Profits Fell 6% in Third Quarter. The Buybacks Are on Pause. -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

Quest Diagnostics Inc Prognoos

Hinnasiht

By TipRanks

9.2% tõus

12 kuu keskmine prognoos

Keskmine 169.57 USD 9.2%

Kõrge 185 USD

Madal 145 USD

Põhineb 14 Wall Streeti analüütiku instrumendi Quest Diagnostics Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

14 ratings

Osta

Hoia

Müü

Põhineb 14 analüütiku instrumendi Quest Diagnostics Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

155.185 / 157.47Toetus ja vastupanu

Bullish events outweigh bearish events.

Recent bearish events outweigh bullish events.

All events are bullish.

Sentiment

By Acuity

93 / 390 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Quest Diagnostics Inc

Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company operates under two segments: Diagnostic Information Services and Diagnostic Solutions. The Diagnostic Information Services develops and delivers diagnostic testing information and services, providing insights that enables a range of customers, including patients, clinicians, hospitals, integrated delivery networks (IDNs), health plans, employers, and accountable care organizations (ACOs). Its Diagnostic Solutions group includes its risk assessment services business, which offers solutions for insurers, and its healthcare information technology businesses, which offers solutions for healthcare providers. The Company's services are provided under the Quest Diagnostics brand, and other brands, such as AmeriPath, Dermpath Diagnostics, ExamOne, Quanum. It also helps in delivering diagnostic insights for COVID-19 and a range of other medical conditions for communities in South Florida.